Literature DB >> 24438143

Epstein-Barr virus-associated T/natural killer-cell lymphomas in the elderly: the first consensus meeting in Kofu 2013.

Toshihisa Hamada1, Shigeo Nakamura, Young-Hyeh Ko, Tadashi Yoshino, Koichi Ohshima, Takamitsu Matsuzawa, Keiko Miura, Toshifumi Takahashi, Hisashi Nomura, Tomomi Hoshino, Daisuke Suzuki, Shinji Shimada, Keiji Iwatsuki.   

Abstract

From a clinicopathological conference on nine elderly patients with Epstein-Barr virus (EBV)-associated T/natural killer (NK)-cell lymphoma, we have addressed the patients' backgrounds, clinical manifestations, histopathological findings, cytogenesis, complications and prognoses. Among these elderly patients (>65 years old), seven patients had extranodal NK/T-cell lymphoma, nasal type (ENKL) with an NK-cell phenotype, and two patients had EBV(+) T-cell lymphomas or lymphoproliferative disorders (LPD) with cutaneous lesions mimicking pityriasis lichenoides et varioliformis acuta (PLEVA) or hydroa vacciniforme (HV). No patients had a previous episode of EBV-related symptoms such as infectious mononucleosis, chronic active EBV infection, HV or hypersensitivity to mosquito bites. Elderly patients with ENKL may show the centroblastoid variant. EBV(+) CD8(+) CD56(+/-) lymphocytes may be responsible for the development of PLEVA or HV-like cutaneous lesions in the elderly.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  Epstein-Barr virus; T/natural killer-cell lymphoma; centroblastoid; hydroa vacciniforme; nasal type

Mesh:

Year:  2014        PMID: 24438143     DOI: 10.1111/1346-8138.12373

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

Review 1.  Nodal EBV+ cytotoxic T-cell lymphoma: A literature review based on the 2017 WHO classification.

Authors:  Seiichi Kato; Daisuke Yamashita; Shigeo Nakamura
Journal:  J Clin Exp Hematop       Date:  2020

2.  Multifocal primary cutaneous extranodal NK/T lymphoma nasal type.

Authors:  Pedro de Vasconcelos; Cristina Ferreira; Luís Soares-Almeida; Paulo Filipe
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.